• 1
    Weiss, R. B., Streptozotocin: a review of its pharmacology, efficacy, and toxicity. Cancer Treat. Rep. 1982. 66: 427438.
  • 2
    Ohly, P., Dohle, C., Abel, J., Seissler, J. and Gleichmann, H., Zinc sulfate induces metallothionein in pancreatic islet of mice and protects against diabetes induced by multiple low doses of streptozotocin. Diabetologia 2000. 43: 10201030.
  • 3
    Friesen, N. T. E., Buchau, A. S., Schott-Ohly, P., Lgssiar, A. and Gleichmann, H., Generation of hydrogen peroxide and failure of antioxidative responses in pancreatic islets of male C57BL/6 mice are associated with diabetes induced by multiple low doses of streptozotocin. Diabetologia 2004. 47: 676685.
  • 4
    Chol, S. E., Noh, H. L, Kim, H. M., Yoon, J. W. and Kang, Y., Streptozotocin upregulates GAD67 expression in MIN6N8a mouse beta cells. J. Autommun. 2002. 19: 18.
  • 5
    Jun, H. S., Chung, H. Y., Han, J., Kim, A., Yoo, S. S., Sherwin, R. S. and Yoon, J. W., Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expression glutamic acid decarboxylase. Diabetologia 2002. 45: 668676.
  • 6
    Han, G., Yan, Li, Wang, J., Wang, R., Chen, G., Song, L., Xu, R. et al., Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expression glutamic acid decarboxylase 65 peptide GAD 500–585. J. Immunol. 2005. 174: 45164524.
  • 7
    Elias, D., Prigozin, H., Polak, N., Rapoport, M., Lohse, A. W. and Cohen, I. R., Autommune diabetes induced by the beta-cell toxin STZ. Immunity to the 60-kDa heat shock protein and to insulin. Diabetes 1994. 43: 992998.
  • 8
    Lukic, M. L., Mensah-Brown, E., Wei, X., Shahin, A., Liew, F. Y., Lack of the mediators of innate immunity attenuates the development of autoimmune diabetes in mice. J. Autoimmun. 2003. 21: 239246.
  • 9
    Mensah-Brown, E. P., Stosic-Grujicic, S., Maksimovic, D., Jasima, A., Shahin, A. and Lukic, M. L., Downregulation of apoptosis in the target tissue prevents low-dose streptozotocin-induced autoimmune diabetes. Mol. Immunol. 2002. 38: 941946.
  • 10
    Stosic-Grujicic, S., Maksimovic, D., Badovinac, V., Samardzic, T., Trajkovic, V., Lukic, M. L. and Mostarica-Stojkovic, M., Antidiabetogenic effect of pentoxifylline is associated with systemic and target tissue modulation of cytokines and nitric oxide production. J. Autoimmun. 2001. 16: 4758.
  • 11
    Lamhamedi-Cherradi, S. E., Zheng, S., Tisch, R. M. and Chen, Y. H., Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes. Diabetes 2003. 52: 22742278.
  • 12
    Nicoletti, F., Di Marco, R., Papaccio, G., Conget, I, Gomis, R., Bernadini, R., Sims, JE. et al., Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct. Eur. J. Immunol. 2003. 33: 22782286.
  • 13
    Pechhold, K., Patterson, N. B., Blum, C., Fleischacker, C. L., Boehm, B. O. and Harlan, D. M., Low dose streptozotocin-induced diabetes in rat insulin promoter-mCD80-transgenic mice is T cell autoantigen-specific and CD28 dependent. J. Immunol. 2001. 166: 25312539.
  • 14
    Trinchieri, G., Pflanz, S. and Kastelein, R. A., The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003. 19: 641644.
  • 15
    Trinchieri, G., Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003. 3: 133146.
  • 16
    Sonobe, Y., Yawata, I., Kawanokuchi, J., Takeuchi, H., Mizuno, T. and Suzumura, A., Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations. Brain Res. 2005. 1040: 202207.
  • 17
    Homo-Delarche, F. and Drexhage, H. A., Immune cells, pancrease development, regeneration and type 1 diabetes. Trends Immunol. 2004. 25: 222229.
  • 18
    Kolb, H., Burkart, V., Appels, B., Hanenberg, H., Kantwerk-Funke, G., Kiesel, U. et al., Essential contribution of macrophages to islet cell destruction in vivo and in vitro. J. Autoimmun. 1990. Suppl 1: 117120.
  • 19
    Lukic, M. L., Stosic-Grujicic, S., and Shahin, A., Effector mechanisms in low-dose streptozotocin-induced diabetes. Dev. Immunol. 1998. 6: 119128.
  • 20
    Haase, C., Skak, K., Michelsen, B. K. and Markholst, H., Local activation of dendritic cells leads to insulitis and development of insulin-dependent diabetes in transgenic mice expression CD154 on the pancreatic β-cells. Diabetes 2004. 53: 25882595.
  • 21
    Tarbell, K. V., Yamazaki, S., Oslon, K., Toy, P. and Steinman, R. M., CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 2004. 199: 14671477.
  • 22
    Krakowski, M: and Owens, T., Inteferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 1996. 26: 16411646.
  • 23
    Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003. 421: 744748.
  • 24
    Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., Mc-Clanahan, T., Kastelein, R. A., Sedgwick, J. D. et al., Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 2003. 198: 19511957.
  • 25
    Lee, E., Trepicchio, W. L., Oestreicher, J. L., Pittman, D., Wang, F., Chamian, F., Dhodapkar, M. and Krueger, JG., Increased expression of interleukin 23 p10 and p40 in lesional skin of patients with psoriasis vulgaris. J. Exp. Med. 2004. 199: 125130.
  • 26
    Windsor, L., Morahan, G., Huang, D., McCann, V., Jones, T., James, I., Christiansen, T. and Price, P., Alleles of the IL12B 3′UTR Associate with late onset of type-1 diabetes. Hum. Immunol. 2004. 65: 14321436.
  • 27
    Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basahm, B., Sedgwick, D., McClanahan, T. et al., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005. 201: 233240.
  • 28
    Lukic, M. L., Stosic-Grujucic, S., Ostojic, N., Chan, W. L. and Liew, F. Y., Inhibition of nitric oxide generation affects the induction of diabetes by streptozotocin in mice. Biochem. Biophys. Res. Commun. 1991. 178: 913920.
  • 29
    Mensah-Brown, E. P., Stosic-Grujicic, S., Maksimovic, D., Jasima, A., Shahin, A. and Lukic, M. L., Downregulation of apoptosis in the target tissue prevents low-dose streptozotocin-induced autoimmune diabetes. Mol. Immunol. 2002. 38: 941946.
  • 30
    Thomas, H. E., Darwiche, R., Corbett, J. A. and Kay, T. W., Interleukin-1 plus gamma-interferon-induced pancreatic beta-cell dysfunction is mediated by beta-cell nitric oxide production. Diabetes 2002. 51: 311316.
  • 31
    Kato, Y., Miura, Y., Yamamoto, N., Ozaki, N. and Oiso, Y., Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction. Diabetologia 2003. 46: 12281233.
  • 32
    Kleemann, R., Rothe, H., Kolb-Bachofen, V., Xie, Q. W., Nathan, C., Martin, S. and Kolb, H., Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett. 1993. 328: 912.
  • 33
    Trembleau, S., Penna, G., Gregori, S., Giarratana, N. and Adorini, L., IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-γ-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-γ. Immunology 2003. 170: 54915501.
  • 34
    Eijnden, S. V., Goriely, S., De Wit, D., Willems, F. and Goldman, M., IL-23 up-regulates IL-10 and induces IL-17 synthesis by polyclonally activated naïve T cells in human. Eur. J. Immunol. 2005, 35: 469475.
  • 35
    Gran, B., Touil, T., Chu, N., Yonghai, L., Zhang, G. X. and Rostami, A. M., Role of IL-23 in experimental autoimmune encephalomyelitis: a paradoxical effect. FASEB J. 2005. 19: A 326 (Abstract 247. 5).
  • 36
    Bettelli, E. and Kuchroo, V. K., IL-12- and IL-23-induced T helper cell subsets: birds of the same feather flock together. J. Exp. Med. 2005. 201: 169171.
  • 37
    Jovanovic, D,V., Di Battista, J. A., Marterl-Pelletier, J., Jolicoeur, F.C., He, Y., Zhang, M., Mineau, F. et al., IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J. Immunol. 1998. 160: 35133521.
  • 38
    Hill, N. and Sarvetnick, N., Cytokines: promoters and dampeners of autoimmunity. Curr. Opin. Immunol. 2002. 14: 791797.
  • 39
    Gysemans, C. A., Pavlovic, D., Bouillon, R., Eizirik, D. L. and Mathieu, C., Dual role of interferon-gamma signaling pathway in sensitivity of pancreatic beta cells to immune destruction. Diabetologia 2001. 44: 567574.
  • 40
    Rasschaert, J., Ladrière, L., Irbain, M., Dogusan, Z., Katabua, B., Sata, S., Akira, S. et al., Toll-like receptor 3 and STAT-1 contribute for dsRNA+IFN-γ-induced apoptosis in primary pancreatic β-cells. J. Biol. Chem. 2005. 280: 3398433991.
  • 41
    Gysemans, C. A., Ladriere, L., Callewaert, H., Rasschaert, J., Flamez, D., Levy, D.E., Matthys, P. et al., Disruption of the γ-interferon signaling pathway at the level of signal transducer and activator of transcription-1 prevents immune destruction of β cells. Diabetes 2005. 54: 23962403.
  • 42
    Miljkovic, D. and Trajkovic, V., Inducible nitric oxide synthase activation by interleukin-17. Cytokine Growth Factor Rev. 2004, 15: 2132.
  • 43
    Van Bezooijen, R. L., Van Der Wee-Pals, L., Papapoulos, S. E. and Lowik, C. W., Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro. Ann. Rheum. Dis. 2002. 61: 870876.
  • 44
    Koenders, M. I., Lubberts, E., Oppers-Walgreen, B., van den Bersselaar, L., Helsen, M. M., Kolls, J. K., Joosten, L. A. et al., Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1. Arthritis Rheum. 2005. 52: 975983.
  • 45
    Happel, K. I., Dubin, P. J., Zheng, M., Ghilardi, N., Lockhart, C., Quinton, L. J., Odden, A. R. et al., Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 2005. 202: 761769.
  • 46
    Lacy, P. E. and Kostianovsky, M., Method of isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967. 16: 3539.
  • 47
    Lernmark, A., The preparation of, and studies on, free cell suspensions from mouse pancreatic islets. Diabetologia 1974. 10: 431438.